BRAWM Trial Approaching Completion
2024-03-14T18:18:45-04:00The WMFC has been closely following the progress of the BRAWM trial because it is the only Canadian clinical treatment trial strictly for WM patients. As Principal Investigator Dr. Neil Berinstein reported in the 2023 ASH conference, “initial clinical results show that this treatment induces a high percentage of CR + VGPRs”. It has come to our attention that there are only 6 spots left in this 59-patient Canadian WM trial. Access for most Canadians is not an issue, as there are 9 (nine!) trial locations across Canada: Halifax, Laval, Montreal, Ottawa, Toronto, Hamilton, Calgary, Edmonton, and Vancouver. As mentioned [...]